补肾温阳化瘀方对子宫内膜异位症血管生成的影响被引量：20

The Effect of Tonifying Kidney Warming yang Removing Blood Stasis Recipe on the Angiogenesis of Endometriosis

在线阅读下载PDF

导出

摘要目的:探讨VEGF、MVD在子宫内膜异位症的表达及意义,探索补肾温阳化瘀方治疗子宫内膜异位症的疗效及机理。方法:采用免疫组织化学SP法测定VEGF、MVD在内异症在位、异位内膜中的表达,采用补肾温阳化瘀方治疗内异症患者50例,观察治疗前后血清中VEGF、CA125的变化。结果:内异症中VEGF、MVD的表达较正常组内膜明显增高(均为P<0.01),中药治疗本病总有效率为82.00%,并且能降低内异症患者血清中VEGF、CA125的含量。结论:VEGF、MVD在内异症中过度表达,提示血管生成是内异症发生发展的重要环节,补肾温阳化瘀方可降低内异症患者血清中VEGF、CA125的含量,阻断内异症的血管生成,促使病灶消散、吸收,并可调节患者紊乱的免疫功能,为治疗内异症的有效方药。 Objective：To detect the expression and meaning of VEGF、MVD in endometriosis and research the mechanism of action of Tonifying kidney warming yang removing blood stasis recipe treated on endometriosis. Methods：Immuno-histochemical staining was used to detect VEGF、MVD expression in eutopic and ectopic endometrium. Apply the recipe to treat the patients with endometriosis and detect the contents of VEGF、CA125 in serum. Results：The expressions of VEGF、MVD in endometriosis were higher than in normal group（ all P 0. 01） ,The total effective rate of traditional Chinese medicine group was 82. 00% ,and the recipe could decrease the content of serum VEGF、CA125 in endometriosis. Conclusion：The overexpressions of VEGF and MVD in endometriosis had a significant relation with angiogenesis,may play an important role in pathogenesis of endometriosis. The recipe could decrease the value of serum VEGF、CA125 of patients with endometriosis,and intercept the angiogenesis in endometriosis,precipitate the ectopic focus disappear、absorption,it is an active recipe to cure endometriosis.

作者陈景伟杜惠兰杨剑刘京芳李清雪马惠荣

机构地区河北医科大学中西医结合学院妇产科学教研室河北省优抚医院内三科河北省中医院妇科石家庄市第四医院妇科

出处《辽宁中医杂志》 CAS 北大核心 2010年第9期1715-1717,共3页 Liaoning Journal of Traditional Chinese Medicine

基金河北省中医药管理局课题(2008001)

关键词子宫内膜异位症血管生成 VEGF MVD CA125 endometriosis angiogenesis VEGF MVD CA125

分类号 R711.71 [医药卫生—妇产科学]

引文网络
相关文献

参考文献3

1王曼,俞瑾,钱祖淇.子宫内膜异位症、妊娠高血压综合征及女性不孕症的中西医结合诊疗标准[J].中西医结合杂志,1991,11(6):376-379. 被引量：582
2宗利丽,李亚里,哈小琴.子宫内膜异位症患者腹水与血清中肝细胞生长因子的检测(英文)[J].第一军医大学学报,2003,23(8):757-760. 被引量：12
3Melaren J. Vascular endothelial growth factor and endometriotic anglogenesis[ J ]. Hum Report Update,2000,6:44 - 45.

二级参考文献12

1GiudiceLC, TazukeSI, SwierszL.Status ofcurrent research on endometriosis[J]. J Reprod Med, 1998, 43 (Suppl): 252-62.
2Sampson JA. Heterotropic or misplaced endometrial tissue [J]. Am J Obstet Gynecol,1925, 10: 649-68.
3Ewa Barcz, Pawel Kaminski, Longin Marianowski. Role ofcytokines in pathogenesis ofendometriosis [J]. Med Sci Monit, 2000, 6(5):1042-6.
4Sugawara J, Fukaya T, Murakami T, et al. Increased secretion of hepatocyte growthfactor by eutopic endometrial stromal cells in women with endometriosis[J]. Fertil Steril,1997, 68(3): 468-72.
5Sezer O, Jakob C, Eucker J, et al. Serum levels of the angiogenic cytokines basicfibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF) and hepatocytegrowth factor (HGF)inmultiple myeloma[ J ]. Eur J Haematol, 2000, 66(2): 83-8.
6Sugawara J, Fukaya T, Murakami T, et al. Hepatocyte growth factor stimulatedproliferation, migration, and lumen formation of human endometrial epithelial cells invitro[J]. Biol Reprod, 1997, 57(4):936-42.
7Thomas EJ, Campbell IG. Evidence that endometriosis behaves in a malignantmanner[J]. Gynecol Obstet Invest, 2000, 50(Suppl 1): 2-10.
8Taylor RN, Lebovic DI, Mueller MD. Angiogenic factor in endometriosis[J]. Ann N YACad Sci, 2002, 955: 89-100.
9Xin X, Yang S, Ingle G, et al. Hepatocyte growth factor enhances vascularendothelial growth factor-induced angiogenesis in vitro and in vivo[J]. Am J Pathol, 2001,158(3): 1111-20.
10Khan KN, Masuzaki H, Fujishita A, et al. Association of interleukin-6 andestradiol with hepatocyte growth factor in peritoneal fluid of women with endometriosis[J]. Acta Obstet Gynecol Scand,2002, 81(8): 764-771.